Complete Genomics is to lay off a "substantial number" of staff at the behest of its parent, China's BGI Genomics, in the midst of the launch of its Revolocity sequencing system, which had already attracted three customers, each paying around $12m. Deliveries of these Revolocity systems will be delayed indefinitely, and Complete Genomics CEO, Reid is to resign. BGI and Complete Genomics did not comment on the reports, hence reasons for the downsizing are unclear.
Complete Genomics is to lay off a "substantial number" of staff at the behest of its parent, China's BGI Genomics, in the midst of the launch of its Revolocity sequencing system, which had already attracted three customers, each paying around $12m. Deliveries of these Revolocity systems will be delayed indefinitely, and Complete Genomics CEO, Cliff Reid is to resign. BGI and Complete Genomics did not comment on the reports, hence reasons for the downsizing are unclear.